A single-center, person-month-based analysis of the risk of developing Pneumocystis pneumonia (PCP) in immunosuppressed non-HIV patients: Preventive effects of trimethoprim-sulfamethoxazole.

Miyake, Kohei; Kawamura, Tetsuji; Nakahara, Yasuharu; Sasaki, Shin

Miyake, Kohei; Kawamura, Tetsuji; Nakahara, Yasuharu; Sasaki, Shin.

Afiliación

Miyake K; Department of Respiratory Medicine, National Hospital Organization Himeji Medical Center, Japan. Electronic address: miyake.kohei.zd@mail.hosp.go.jp.
Kawamura T; Department of Respiratory Medicine, National Hospital Organization Himeji Medical Center, Japan.
Nakahara Y; Department of Respiratory Medicine, National Hospital Organization Himeji Medical Center, Japan.
Sasaki S; Department of Respiratory Medicine, National Hospital Organization Himeji Medical Center, Japan.

J Infect Chemother ; 29(12): 1097-1102, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37499901

Palabras clave

Chemotherapy; Immunosuppressant; Person-month analysis; Pneumocystis pneumonia; Risk factor; Trimethoprim-sulfamethoxazole

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Infect Chemother Asunto de la revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google